Skip to main content
All lobbying firms

ALB SOLUTIONS

Registrant on federal lobbying filings · filed 2025 to 2026

$3,710,000 Income reported
15 Clients represented
91 Filings counted
0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. 2 filings on this record were restated by a later amendment and are left out of every total here. Everything on this page is grouped by the registrant's LDA id (401105973), not by name.

 Clients 15
 Lobbyists named 2
  • ADAM BUCKALEW 93 filings · through 2026 Covered Official Positions Continued: Deputy Chief of Staff, U.S. Rep. Markwayne Mullin (R-OK); Communications Director & Legislative Assistant, U.S. Rep. Gregg…
  • VERONICA JACKSON 80 filings · through 2026 Director, Strategic Planning, Office of the Assistant Secretary for Public Affairs, HHS

A lobbyist who previously held a covered government position must disclose it. We flag the ones whose name resolves to a member of Congress and link the ones still in our roster. The revolving door collects them across every firm.

 Reported by year 2 years
  • 2026 $2,010,000 50 filings
  • 2025 $1,700,000 41 filings
 Issues lobbied 7

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 5
  • HOUSE OF REPRESENTATIVES 85
  • SENATE 85
  • Health & Human Services, Dept of (HHS) 27
  • White House Office 13
  • Food & Drug Administration (FDA) 3
 Recent filings 93 total
Q3 report
BLOOD CANCER UNITED
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $30,000 income · posted Oct 20, 2026
View →
Q2 amendment
BLOOD CANCER UNITED
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $30,000 income · posted Oct 20, 2026
View →
Q1 amendment
BLOOD CANCER UNITED
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $20,000 income · posted Oct 20, 2026
View →
Q3 report
VERTEX PHARMACEUTICALS
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2026
View →
Q3 report
SALT POINT STRATEGIES ON BEHALF OF THE RITEDOSE CORPORATION
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $30,000 income · posted Oct 20, 2026
View →
Q3 report
INDEPENDENCE BLUE CROSS
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 20, 2026
View →
Q3 report
HUMANA, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 report
ELEVANCE HEALTH, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 report
CVS HEALTH (AND SUBSIDIARIES)
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $70,000 income · posted Oct 20, 2026
View →
Q3 report
CIGNA CORPORATE SERVICES, LLC AND ITS AFFILIATES
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2026
View →
Q3 report
CENTENE CORPORATIONS
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $30,000 income · posted Oct 20, 2026
View →
Q3 report
CAREVISO INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $20,000 income · posted Oct 20, 2026
View →
Q3 report
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 20, 2026
View →
Q3 report
BLUE CROSS AND BLUE SHIELD ASSOCIATION
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 report
BETTER SOLUTIONS FOR HEALTHCARE
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2026
View →
Q3 report
AMERICAN HEART ASSOCIATION
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $20,000 income · posted Oct 20, 2026
View →
Q3 report
AIS HEALTHCARE
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2026
View →
Q2 report
VERTEX PHARMACEUTICALS
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 16, 2026
View →
Q2 report
SALT POINT STRATEGIES ON BEHALF OF THE RITEDOSE CORPORATION
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $30,000 income · posted Jul 16, 2026
View →
Q2 report
INDEPENDENCE BLUE CROSS
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $40,000 income · posted Jul 16, 2026
View →

Showing the 20 most recent of 93 filings. Search the explorer for "ALB SOLUTIONS".

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem